Table 4 Outcomes and cost-effectiveness of secondary prevention for diabetic foot
Comparison | Standard care vs. sub-optimal care | Standard care plus temperature monitoring vs. sub-optimal care | Standard care plus temperature monitoring vs. standard care |
|---|---|---|---|
Differences in costs (∆ costs) | |||
Direct costs | -US$2,724,815 | US$22,329,464 | US$25,054,279 |
Direct costs + Indirect costs | -US$8,037,824 | US$13,024,440 | US$21,062,264 |
Differences in deaths (∆ deaths) | 791 | 1,385 | 594 |
Differences in major amputations | 2,087 | 3,656 | 1,568 |
Incremental cost-effectiveness ratio (∆ costs/∆ deaths) | |||
Direct costs | Cost-saving | ICER = 16,124 | ICER = 42,169 |
Direct costs + Indirect costs | Cost-saving | ICER = 9,405 | ICER = 35,450 |